Skip to content

Medical Disclaimer: For reference only; may contain errors. Reconfirm with a qualified physician before clinical use. Report an error

ENDOCRINOLOGY & DIABETOLOGY

HbA1c Converter & Target Interpreter

Instant bidirectional conversion between DCCT %, IFCC mmol/mol, and estimated Average Glucose (eAG) in mg/dL and mmol/L. Includes ADA 2024 and RSSDI clinical target stratification.

Free to useADA / RSSDI AlignedInstant conversion
🩸

HbA1c Unit Converter

DCCT · IFCC · eAG (mg/dL & mmol/L)

Diabetology
%
📋 Contents — tap to expand
👨‍⚕️
Reviewed by Dr. Sharma, MBBS AFIH

Medical Officer, AAC Clinic · Updated 2026-06-09

1About HbA1c — Interpretation & Diabetes Targets

HbA1c (Glycated Haemoglobin) reflects average plasma glucose over the preceding 2–3 months (the average erythrocyte lifespan) and represents the gold standard metric for chronic glycaemic monitoring. It is expressed as a percentage (NGSP/DCCT standard) or in mmol/mol (IFCC international standard).

IFCC mmol/mol = (DCCT% − 2.15) × 10.929
eAG (mg/dL) = (28.7 × DCCT%) − 46.7
eAG (mmol/L) = eAG (mg/dL) ÷ 18.016

Diagnostic thresholds per ADA 2024 and RSSDI India guidelines:

  • Normal: < 5.7% (< 39 mmol/mol)
  • Prediabetes: 5.7% – 6.4% (39 – 47 mmol/mol)
  • Diabetes Mellitus: ≥ 6.5% (≥ 48 mmol/mol) confirmed on two occasions

When is HbA1c unreliable? Red cell lifespan alterations cause substantial discordance. Conditions that falsely decrease HbA1c include haemolytic anaemia, hemoglobinopathies (HbS, HbE, HbC, thalassaemia variants), acute blood loss, and recent transfusion. Conversely, iron-deficiency anaemia and severe renal impairment with carbamylated haemoglobin spuriously elevate reported HbA1c. In such settings, fructosamine or glycated albumin should be utilized.

2HbA1c & eAG Reference Conversion Table

DCCT (%)IFCC (mmol/mol)eAG (mg/dL)eAG (mmol/L)Clinical Category

3Frequently Asked Questions

Medical Disclaimer: This converter is designed for informational and clinical decision-support purposes only. Mathematical translations reflect standard ADAG regression formulas. Therapeutic decisions should account for individualized clinical risk, continuous glucose monitoring trends, and co-morbid factors.

Related Calculators